Jonas, O., Oudin, M. J., Kosciuk, T., Whitman, M., Gertler, F. B., Cima, M. J., . . . Langer, R. (2016). Parallel in-vivo assessment of drug phenotypes at various time points during systemic BRAF inhibition reveals tumor adaptation and altered treatment vulnerabilities. Clin Cancer Res.

Jonas, Oliver, Madeleine J. Oudin, Tatsiana Kosciuk, Matthew Whitman, Frank B. Gertler, Michael J. Cima, Keith T. Flaherty, and Robert Langer. "Parallel In-vivo Assessment of Drug Phenotypes At Various Time Points During Systemic BRAF Inhibition Reveals Tumor Adaptation and Altered Treatment Vulnerabilities." Clin Cancer Res 2016.

Jonas, Oliver, et al. "Parallel In-vivo Assessment of Drug Phenotypes At Various Time Points During Systemic BRAF Inhibition Reveals Tumor Adaptation and Altered Treatment Vulnerabilities." Clin Cancer Res 2016.